Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estera Okon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Molecular Sciences|April 25, 2020
Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological OriginEstera Okon, Jarogniew J Luszczki, Wirginia Kukula-Koch, et al.
Cancers|January 30, 2019
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer CellsAnna Wawruszak, Joanna Kalafut, Estera Okon, et al.
Cancer Management and Research|October 2, 2019
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory propertiesAnna Wawruszak, Ewelina Gumbarewicz, Estera Okon, et al.
Biomolecules|November 13, 2020
Magnoflorine-Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer CellsEstera Okon, Wirginia Kukula-Koch, Marta Halasa, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Molecular Sciences|April 25, 2020
Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological OriginEstera Okon, Jarogniew J Luszczki, Wirginia Kukula-Koch, et al.
Cancers|January 30, 2019
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer CellsAnna Wawruszak, Joanna Kalafut, Estera Okon, et al.
Cancer Management and Research|October 2, 2019
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory propertiesAnna Wawruszak, Ewelina Gumbarewicz, Estera Okon, et al.
Biomolecules|November 13, 2020
Magnoflorine-Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer CellsEstera Okon, Wirginia Kukula-Koch, Marta Halasa, et al.
Pageof 2